Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi Pasteur MSD

www.spmsd.com

Latest From Sanofi Pasteur MSD

Deal Watch: Sanofi Begins 2017 By Ending Vaccine JV, Completing Swap With Boehringer

At year's end the French pharma also announced a restructuring of its broad diabetes collaboration with South Korea’s Hanmi. In a deal involving two other French companies, OSE out-licensed global development and commercial rights to an IL-7 antagonist to Servier.

Deals M & A

Oncology Captures One In Three New EU Drug Approvals In 2016

2016 saw 30 new active substances approved in the EU, in a total of 29 different products, of which 10 were for cancer indications. Also approved were a range of combinations of old and new drugs, some new uses, and a number of biosimilars and generics. 14 of the products approved during the year were for rare diseases, while eight received a conditional marketing authorization.

Approvals BioPharmaceutical

European Notebook: All Change In The C-Suites; EMA PRIME Starts; French Experts Recommend Phase I Changes

Once-in-a-decade leadership changes stack up in Europe’s big pharma companies as the region aims for quicker and more certain drug development, although following a recent fatality an expert committee is advising caution during dose-escalation in Phase I studies.

BioPharmaceutical Europe

Deal Watch: Orexigen And Takeda Call It Quits, AbbVie And Boehringer Join Forces

AbbVie pays $595m up front for rights to Boehringer's Phase III anti-IL-23 candidate, which it sees as a potential competitor to Stelara. Merck and Sanofi end their European vaccines joint venture after a 22-year run.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Pasteur Merieux MSD
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Sanofi Pasteur MSD
  • Senior Management
  • Didier Blondel, VP, CFO
    David Khougazian, Pres.
    Hugo Fry, VP, Chief Marketing Officer
    Stephen Lockhart, VP, Dev.
  • Contact Info
  • Sanofi Pasteur MSD
    Phone: (33) 4 37 28 40 00
    162, Avenue Jean Jaurès
    CS 50712
    Lyon, 69367
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register